缓释对乙酰氨基酚过量:一项前瞻性观察研究(ATOM-3)
该前瞻性观察研究于2013年1月至2017年6月在澳大利亚五个临床毒理学单元及两个中毒信息中心招募了116例急性缓释对乙酰氨基酚过量患者(摄入≥10 g或200 mg/kg,取较小者)。中位摄入剂量32 g,中位就诊时间3小时,67%初始对乙酰氨基酚浓度高于列线图线,10%复查后越过列线图。97%接受乙酰半胱氨酸治疗,其中67例延长治疗超过标准21小时;18%发生肝毒性(ALT>1000 U/L),包括6例在摄入8小时内治疗者。活性炭和双倍剂量乙酰半胱氨酸未显著降低肝毒性风险。作者认为需要研究更好的治疗策略。
要点
- 急性缓释对乙酰氨基酚过量患者中67%(78/116)初始对乙酰氨基酚浓度高于列线图线(4小时150 mg/L),10%(12/116)复查后越过列线图。
- 97%(113/116)接受乙酰半胱氨酸治疗,其中67例延长治疗超过标准21小时,39例因乙酰半胱氨酸完成时对乙酰氨基酚浓度升高(中位25 mg/L,IQR 16-62 mg/L)。
- 18%(21/116)发生肝毒性(ALT>1000 U/L),包括6例在摄入8小时内接受治疗者。
- 活性炭和双倍剂量乙酰半胱氨酸未显著降低肝毒性风险。
- 作者认为需要研究更好的治疗策略;药物监管机构正在考虑限制缓释对乙酰氨基酚制剂。
适用人群与场景
- 年龄>14岁、摄入≥10 g或200 mg/kg(取较小者)缓释对乙酰氨基酚的患者,来自澳大利亚五个临床毒理学单元及两个中毒信息中心(2013年1月至2017年6月)。
诊断标准与关键阈值
- 肝毒性定义为ALT>1000 U/L。
- 初始对乙酰氨基酚浓度高于列线图线定义为4小时150 mg/L。
处置流程与药物剂量
- 113例(97%)接受乙酰半胱氨酸治疗,其中67例延长治疗超过标准21小时;39例因乙酰半胱氨酸完成时对乙酰氨基酚浓度升高(中位25 mg/L,IQR 16-62 mg/L)而延长。
- 活性炭和双倍剂量乙酰半胱氨酸未显著降低肝毒性风险。
研究设计与关键结果
- 前瞻性观察研究,纳入116例患者,85例(73%)为女性;中位摄入剂量32 g(IQR 20-49 g),中位就诊时间3小时(IQR 2-9小时)。
- 78例(67%)初始对乙酰氨基酚浓度高于列线图线(4小时150 mg/L);12例(10%)复查后越过列线图,其中5例在两次间隔4小时的非毒性浓度后越过。
- 6例出现双峰对乙酰氨基酚浓度,其中3例第二峰出现在摄入后>24小时。
- 21例(18%)发生肝毒性(ALT>1000 U/L),包括6例在摄入8小时内接受治疗者。
- 活性炭和双倍剂量乙酰半胱氨酸未显著降低肝毒性风险。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,急性缓释对乙酰氨基酚过量后许多患者对乙酰氨基酚浓度持续升高、许多需要延长治疗,部分尽管早期乙酰半胱氨酸治疗仍发生肝损伤;活性炭和增加乙酰半胱氨酸似乎未显著改变肝损伤风险,需要研究更好的治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Modified-release (MR) paracetamol is available in many countries as 665 mg tablets of which 69% is MR and 31% is immediate release. There are concerns that MR paracetamol overdose has higher rates of liver injury despite standard treatment algorithms. The objective of this study was to describe the clinical characteristics and outcomes of acute MR paracetamol overdose.
METHODS: Prospective observational study, recruiting patients from January 2013 to June 2017, from five clinical toxicology units and calls to two Poisons Information Centres in Australia. Included were patients >14 years who ingested ≥10 g or 200 mg/kg (whichever is less) of MR paracetamol. Data collected included demographics, ingestion history, pathology results, treatments, and outcomes including hepatotoxicity (ALT >1000 U/L).
RESULTS: In total, 116 patients were recruited, 85(73%) were female. The median dose ingested was 32 g (IQR: 20-49 g) and median time to presentation was 3 h (IQR: 2-9 h). 78(67%) had an initial paracetamol concentration above the nomogram line (150 mg/L at 4 h). A further 12(10%) crossed the nomogram after repeat paracetamol measurements, of which five crossed after two non-toxic levels 4 h apart. Six had a double paracetamol peak, in three occurring >24 h post-ingestion. 113(97%) received acetylcysteine of which 67 received prolonged treatment beyond the standard 21 h. This was because of an elevated paracetamol concentration at the completion of acetylcysteine in 39 (median paracetamol concentration 25 mg/L, IQR: 16-62 mg/L). 21 (18%) developed hepatotoxicity, including six treated within 8 h of ingestion. Activated charcoal and double doses of acetylcysteine did not significantly decrease the risk of hepatotoxicity.
CONCLUSIONS: Drug regulatory authorities are considering restrictions on MR paracetamol preparations. Following an acute MR paracetamol overdose, this study found that many patients had a persistently elevated paracetamol concentrations, many required prolonged treatment and some developed liver injury despite early acetylcysteine treatment. Furthermore, activated charcoal and increased acetylcysteine did not appear to significantly alter the risk of liver injury. Hence, research into better treatment strategies is required.
TRIAL REGISTRATION: Australian Toxicology Monitoring (ATOM) Study - Australian Paracetamol Project: ACTRN12612001240831 (ANZCTR) Date of registration: 23/11/2012.
参考来源
- Chiew AL, Isbister GK, Page CB, et al. Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clin Toxicol (Phila). 2018. PMID: 29451045. doi:10.1080/15563650.2018.1439950
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。